SRHQ - ETF AI Analysis
Top Page
SRH U.S. Quality ETF (SRHQ)
Rating:70Neutral
Price Target:―
Positive Factors
Solid Recent Performance
The ETF has shown strong gains so far this year and in recent months, indicating positive momentum.
Broad Sector Diversification
Holdings are spread across many sectors, with meaningful exposure to industrials, technology, and health care, which helps reduce reliance on any single industry.
Growing Mid-Sized Fund
With nearly two hundred million dollars in assets, the fund is large enough to be established but still small enough to remain flexible in its stock selection.
Negative Factors
Higher-Than-Index Expense Ratio
The fund’s fee is higher than many broad U.S. index ETFs, which can slightly reduce long-term returns.
Mixed Performance Among Top Holdings
Several of the largest positions have weak or negative year-to-date performance, which could drag on future returns if they do not recover.
Heavy U.S.-Only Exposure
Almost all assets are invested in U.S. companies, offering little diversification benefit from international markets.
SRHQ vs. SPDR S&P 500 ETF (SPY)
AUM203.37M
RegionNorth America
Expense Ratio0.35%
Beta0.82
IssuerSRH
Inception DateOct 05, 2022
Dividend Yield0.71%
Asset ClassEquity
Index TrackedSRH U.S. Quality GARP Index - Benchmark TR Gross
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume391
30 Day Avg. Volume449
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
52.59Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering80
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
SRHQ Summary
SRH U.S. Quality ETF (SRHQ) is a U.S. stock fund that follows the SRH U.S. Quality GARP Index, focusing on large, financially strong companies. It holds a mix of industries like technology, health care, and industrials, and includes well-known names such as UnitedHealth and Humana. Someone might invest in this ETF to get broad, diversified exposure to high-quality U.S. companies with the potential for steady long-term growth. A key risk is that it still invests fully in the stock market, so its value can go up and down with overall market conditions.
How much will it cost me?The SRH U.S. Quality ETF (SRHQ) has an expense ratio of 0.35%, which means you’ll pay $3.50 per year for every $1,000 invested. This is slightly higher than the average for ETFs because it is actively managed, focusing on selecting high-quality large-cap companies rather than simply tracking an index.
What would affect this ETF?The SRH U.S. Quality ETF (SRHQ), with its focus on large-cap U.S. companies in sectors like Technology, Industrials, and Health Care, could benefit from economic growth, technological innovation, and increased demand for healthcare services. However, it may face challenges from rising interest rates, which can impact large-cap companies' borrowing costs, or sector-specific risks such as regulatory changes in technology and healthcare. Its emphasis on quality companies provides resilience, but broader market volatility could still affect performance.
SRHQ Top 10 Holdings
SRHQ leans heavily into U.S. industrial and health care leaders, and that’s where much of the action is. Sterling Infrastructure and Arcosa have been the fund’s workhorses, riding strong momentum in construction and infrastructure to pull performance higher. On the health care side, UnitedHealth and Humana are steady climbers, helping smooth out bumps elsewhere. Centene and Insperity, however, look more mixed, occasionally losing their footing and tempering gains. With all holdings U.S.-based and spread across quality large caps, the ETF still avoids being overly tied to any single name.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Humana | 2.53% | $5.23M | $47.63B | 66.16% | 69 Neutral | |
| Centene | 2.25% | $4.66M | $33.51B | 102.82% | 58 Neutral | |
| CommVault Systems | 2.15% | $4.45M | $6.21B | -11.05% | 65 Neutral | |
| Qualys | 2.01% | $4.16M | $5.22B | 7.09% | 78 Outperform | |
| Sterling Infrastructure | 1.97% | $4.07M | $21.50B | 215.88% | 71 Outperform | |
| Insperity | 1.83% | $3.78M | $1.73B | -25.83% | 54 Neutral | |
| Credit Acceptance | 1.73% | $3.59M | $6.87B | 22.99% | 71 Outperform | |
| UnitedHealth | 1.73% | $3.57M | $386.29B | 35.84% | 72 Outperform | |
| frontdoor | 1.67% | $3.46M | $5.51B | 34.59% | 72 Outperform | |
| Gen Digital | 1.58% | $3.26M | $16.07B | -10.55% | 67 Neutral |
SRHQ Technical Analysis
Positive
―
Price Trends
44.41
Positive
42.92
Positive
41.13
Positive
Market Momentum
0.71
Negative
64.81
Neutral
59.73
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For SRHQ, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 45.46, equal to the 50-day MA of 44.41, and equal to the 200-day MA of 41.13, indicating a bullish trend. The MACD of 0.71 indicates Negative momentum. The RSI at 64.81 is Neutral, neither overbought nor oversold. The STOCH value of 59.73 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SRHQ.
SRHQ Peer Comparison
Comparison Results
Performance Comparison
SRHQ
SRH U.S. Quality ETF
46.62
9.70
26.27%
SPHB
Invesco S&P 500 High Beta ETF
―
―
―
QLC
FlexShares US Quality Large Cap Index Fund
―
―
―
DSPY
Tema S&P 500 Historical Weight ETF Strategy
―
―
―
FTQI
First Trust Hedged BuyWrite Income ETF
―
―
―
OMAH
VistaShares Target 15 Berkshire Select Income ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents